Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Hair transplantation might work for some people with frontal fibrosing alopecia, but more research is needed.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Trichoscopy effectively diagnoses eyebrow loss, distinguishing between alopecia areata and frontal fibrosing alopecia.

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.